Showing results (441-450 of 576) with videos related to

Sort By:
Pageof 58
Neuroscience Letters|October 19, 2010
LINGO1 rs9652490 variant in Parkinson disease patientsYi Guo, Joseph Jankovic, Zhi Song, et al.
Parkinsonism & Related Disorders|August 22, 2020
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment toolRoongroj Bhidayasiri, John M Kane, Karen P Frei, et al.
The Lancet. Neurology|November 27, 2019
Essential tremor-plus: a controversial new conceptElan D Louis, Martin Bares, Julian Benito-Leon, et al.
The New England Journal of Medicine|September 25, 2009
A double-blind, delayed-start trial of rasagiline in Parkinson's diseaseC Warren Olanow, Olivier Rascol, Robert Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 22, 2008
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristicsC Warren Olanow, Robert A Hauser, Joseph Jankovic, et al.
Neurology|January 31, 2024
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled TrialCynthia L Comella, Joseph Jankovic, Robert A Hauser, et al.
American Journal of Clinical Pathology|March 18, 2008
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseasesJing Zhang, Izabela Sokal, Elaine R Peskind, et al.
Parkinsonism & Related Disorders|April 17, 2007
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's diseaseL Warren, R Gibson, L Ishihara, et al.
Pageof 58